BiotechTube
Home/Iterum Therapeutics/Michael Dunne
MD

Michael Dunne

Director

Iterum Therapeutics

Therapeutic Areas

Infectious DiseaseAntimicrobial Resistance

Iterum Therapeutics Pipeline

DrugIndicationPhase
ORLYNVAH™ (sulopenem)Uncomplicated Urinary Tract Infection (uUTI)Approved

Leadership Team at Iterum Therapeutics

CN
Corey N. Fishman
Chief Executive Officer
JM
Judith M. Matthews
Chief Financial Officer
CR
Christine R. Coyne
Chief Commercial Officer
TL
Tom Loughman
Senior Vice President, Technical Operations
BP
Beth P. Hecht
Director
View full Iterum Therapeutics profile